Found 47 matching trials
An Indian Post Marketing Study of Mealtime Insulin, Fiasp®, to Evaluate Its Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice N/A This study is to investigate the effects of Fiasp®, a mealtime insulin, in ...
Show More Learn More & Join Trial
Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes PHASE3 This trial is conducted in Asia, Europe, South America, and the United Stat...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Closed-Loop With Faster Aspart in Young Adults With Type 1 Diabetes NA A randomized, double-blinded (for insulin type), single centre, crossover d...
Show More Location
UMC-University Children's Hospital
Learn More & Join Trial
Comparison of Day and Night Closed-loop With Faster-acting Insulin Aspart With Insulin Aspart NA The main objective of the study is to determine whether automated closed-lo...
Show More Location
Manchester University Hospitals NHS Foundation Trust
Learn More & Join Trial
A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes PHASE1 This trial is conducted in Europe. The aim of the trial is to investigate t...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes Mellitus PHASE1 A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes PHASE1 This trial is conducted in Europe. The aim of the trial is to investigate t...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes PHASE1 This trial is conducted in Europe and in the United States of America (USA)...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes PHASE1 This trial is conducted in the United States of America (USA). The aim of t...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
FASter Insulin in Closed-loop Technology in Children NA The main objective of this study is to determine whether 24/7 hybrid closed...
Show More Location
University Department of Paediatrics
Learn More & Join Trial